id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT03042897 | 16:31:chronic_disease,33:50:chronic_disease,54:75:chronic_disease | History of any musculoskeletal, cardiorespiratory or neurological diseases that preclude the participation in exercise | 3 | [
"History",
"of",
"any",
"musculoskeletal",
",",
"cardiorespiratory",
"or",
"neurological",
"diseases",
"that",
"preclude",
"the",
"participation",
"in",
"exercise"
] | [
0,
0,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02824276 | 24:52:chronic_disease | current (i.e., active) substance use disorder (SUD) | 3 | [
"current",
"(",
"i.e.",
",",
"active",
")",
"substance",
"use",
"disorder",
"(",
"SUD",
")"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02474667 | 34:55:treatment | Patients cannot be given another investigational agent during the course of this study (through Day 360) | 3 | [
"Patients",
"can",
"not",
"be",
"given",
"another",
"investigational",
"agent",
"during",
"the",
"course",
"of",
"this",
"study",
"(",
"through",
"Day",
"360",
")"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02333162 | 1:35:chronic_disease | Human immunodeficiency virus (HIV)-negative | 3 | [
"Human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"-negative"
] | [
2,
2,
2,
2,
0,
0,
0
] |
NCT00338377 | ,,62:103:treatment | Absolute neutrophil count greater than or equal to 750/mm3. (Turnstile II - Chemotherapy/Cell Infusion- Inclusion Criteria) | 3 | [
"Absolute",
"neutrophil",
"count",
"greater",
"than",
"or",
"equal",
"to",
"750/mm3",
".",
"(",
"Turnstile",
"II",
"-",
"Chemotherapy/Cell",
"Infusion-",
"Inclusion",
"Criteria",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0
] |
NCT02143726 | 1:18:treatment,7:18:treatment,7:10:treatment,, | Prior RAI therapy is allowed if ≥ 90 days prior to registration on this protocol and evidence of progression (as defined above) has been documented in the interim (a diagnostic study using < 10 mCi of RAI is not considered RAI therapy) | 3 | [
"Prior",
"RAI",
"therapy",
"is",
"allowed",
"if",
"≥",
"90",
"days",
"prior",
"to",
"registration",
"on",
"this",
"protocol",
"and",
"evidence",
"of",
"progression",
"(",
"as",
"defined",
"above",
")",
"has",
"been",
"documented",
"in",
"the",
"interim",
"... | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03065465 | 21:53:treatment | requires continuous intravenous vasopressor infusion for blood pressure support | 3 | [
"requires",
"continuous",
"intravenous",
"vasopressor",
"infusion",
"for",
"blood",
"pressure",
"support"
] | [
0,
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT02278250 | 23:30:treatment,85:96:treatment,100:109:treatment | During prior platinum therapy, requirement for dose reduction or discontinuation of carboplatin or cisplatin for toxicity or lack of tolerability | 3 | [
"During",
"prior",
"platinum",
"therapy",
",",
"requirement",
"for",
"dose",
"reduction",
"or",
"discontinuation",
"of",
"carboplatin",
"or",
"cisplatin",
"for",
"toxicity",
"or",
"lack",
"of",
"tolerability"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01239095 | 21:33:cancer | Patients with other malignancies are not eligible | 3 | [
"Patients",
"with",
"other",
"malignancies",
"are",
"not",
"eligible"
] | [
0,
0,
0,
3,
0,
0,
0
] |
NCT02203513 | 1:22:chronic_disease, | myocardial infarction within the last 3 months | 3 | [
"myocardial",
"infarction",
"within",
"the",
"last",
"3",
"months"
] | [
2,
2,
0,
0,
0,
0,
0
] |
NCT02561988 | 1:24:cancer | metastases to the brain | 3 | [
"metastases",
"to",
"the",
"brain"
] | [
3,
3,
3,
3
] |
NCT01766297 | 1:32:cancer | ductal carcinoma in situ (DCIS) | 3 | [
"ductal",
"carcinoma",
"in",
"situ",
"(",
"DCIS",
")"
] | [
3,
3,
3,
3,
3,
0,
0
] |
NCT01618357 | 1:17:treatment | Hepatic Function | 3 | [
"Hepatic",
"Function"
] | [
1,
1
] |
NCT03037879 | 22:30:treatment,32:47:treatment,52:64:treatment | Currently prescribed steroids, benzodiazepines, or neuroleptics | 3 | [
"Currently",
"prescribed",
"steroids",
",",
"benzodiazepines",
",",
"or",
"neuroleptics"
] | [
0,
0,
1,
0,
1,
0,
0,
1
] |
NCT01459107 | 1:17:chronic_disease | Hepatitis B or C | 3 | [
"Hepatitis",
"B",
"or",
"C"
] | [
2,
2,
2,
2
] |
NCT02143726 | 1:14:chronic_disease | Liver disease | 3 | [
"Liver",
"disease"
] | [
2,
2
] |
NCT03032432 | 12:32:chronic_disease | History of rheumatoid arthritis | 3 | [
"History",
"of",
"rheumatoid",
"arthritis"
] | [
0,
0,
2,
2
] |
NCT01925131 | 56:79:treatment | Patients must be refractory or have relapsed following prior induction therapy | 3 | [
"Patients",
"must",
"be",
"refractory",
"or",
"have",
"relapsed",
"following",
"prior",
"induction",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01804465 | 27:48:chronic_disease,123:133:treatment,227:235:chronic_disease | Any underlying medical or psychiatric condition, which in the opinion of the investigator will make the administration of ipilimumab hazardous or obscure the interpretation of AEs, such as a condition associated with frequent diarrhea | 3 | [
"Any",
"underlying",
"medical",
"or",
"psychiatric",
"condition",
",",
"which",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
"will",
"make",
"the",
"administration",
"of",
"ipilimumab",
"hazardous",
"or",
"obscure",
"the",
"interpretation",
"of",
"AEs",
... | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT03096886 | 1:18:chronic_disease | learning disorder | 3 | [
"learning",
"disorder"
] | [
2,
2
] |
NCT02303977 | ,,86:96:treatment | Patients must agree to continue contraception for 3 months from the date of the last study drug administration | 3 | [
"Patients",
"must",
"agree",
"to",
"continue",
"contraception",
"for",
"3",
"months",
"from",
"the",
"date",
"of",
"the",
"last",
"study",
"drug",
"administration"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT01766297 | 1:28:cancer,37:44:cancer,48:56:cancer | Non-epithelial malignancies such as sarcoma or lymphoma | 3 | [
"Non-epithelial",
"malignancies",
"such",
"as",
"sarcoma",
"or",
"lymphoma"
] | [
3,
3,
0,
0,
3,
0,
3
] |
NCT01804634 | 1:8:chronic_disease | Cardiac | 3 | [
"Cardiac"
] | [
2
] |
NCT02003222 | ,243:296:treatment | Diagnostic bone marrow and peripheral blood specimens must be submitted for immunophenotyping and selected molecular testing, and the establishment of BCR/ABL status; testing will be performed by the Eastern Cooperative Oncology Group (ECOG)-American College of Radiation Imaging Network (ACRIN) Leukemia Translational R... | 3 | [
"Diagnostic",
"bone",
"marrow",
"and",
"peripheral",
"blood",
"specimens",
"must",
"be",
"submitted",
"for",
"immunophenotyping",
"and",
"selected",
"molecular",
"testing",
",",
"and",
"the",
"establishment",
"of",
"BCR/ABL",
"status",
";",
"testing",
"will",
"be"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02758847 | 118:161:treatment | Iliac inflow or Tibial outflow interventions can be done at the discretion of the investigator with standard balloon Percutaneous Transluminal Angioplasty (PTA) | 3 | [
"Iliac",
"inflow",
"or",
"Tibial",
"outflow",
"interventions",
"can",
"be",
"done",
"at",
"the",
"discretion",
"of",
"the",
"investigator",
"with",
"standard",
"balloon",
"Percutaneous",
"Transluminal",
"Angioplasty",
"(",
"PTA",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02148003 | 58:82:chronic_disease | Subjects who have chronic back pain attributed to lumbar facet joints arthropathy based on clinical evaluation (paraspinal tenderness and/or facet loading test in the absence of signs and symptoms suggestive of focal neurological deficits) | 3 | [
"Subjects",
"who",
"have",
"chronic",
"back",
"pain",
"attributed",
"to",
"lumbar",
"facet",
"joints",
"arthropathy",
"based",
"on",
"clinical",
"evaluation",
"(",
"paraspinal",
"tenderness",
"and/or",
"facet",
"loading",
"test",
"in",
"the",
"absence",
"of",
"s... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02068092 | 18:31:cancer,,105:114:chronic_disease,122:140:treatment | Elevated risk of breast cancer as defined by at least one of the following categories and have declined tamoxifen and/or raloxifene therapy | 3 | [
"Elevated",
"risk",
"of",
"breast",
"cancer",
"as",
"defined",
"by",
"at",
"least",
"one",
"of",
"the",
"following",
"categories",
"and",
"have",
"declined",
"tamoxifen",
"and/or",
"raloxifene",
"therapy"
] | [
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
1,
1
] |
NCT02674529 | 7:33:chronic_disease | other Axis I psychotic disorders | 3 | [
"other",
"Axis",
"I",
"psychotic",
"disorders"
] | [
0,
2,
2,
2,
2
] |
NCT02762825 | 1:56:chronic_disease | moderate to severe (grade II-III) diastolic dysfunction | 3 | [
"moderate",
"to",
"severe",
"(",
"grade",
"II-III",
")",
"diastolic",
"dysfunction"
] | [
2,
2,
2,
2,
2,
2,
2,
0,
0
] |
NCT01459107 | 1:19:chronic_disease | Viral encephalitis | 3 | [
"Viral",
"encephalitis"
] | [
2,
2
] |
NCT02048722 | 23:30:treatment | Prophylactic doses of heparin | 3 | [
"Prophylactic",
"doses",
"of",
"heparin"
] | [
0,
0,
0,
1
] |
NCT02109627 | 1:13:treatment,15:24:treatment,29:42:treatment,,135:146:treatment,151:173:treatment | Chemotherapy, radiation, or immunotherapy, within 2 weeks prior to study entry, other than those specified in the inclusion criteria (hydroxyurea and hypomethylating agents) | 3 | [
"Chemotherapy",
",",
"radiation",
",",
"or",
"immunotherapy",
",",
"within",
"2",
"weeks",
"prior",
"to",
"study",
"entry",
",",
"other",
"than",
"those",
"specified",
"in",
"the",
"inclusion",
"criteria",
"(",
"hydroxyurea",
"and",
"hypomethylating",
"agents",
... | [
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0
] |
NCT02791646 | 15:43:chronic_disease,22:43:chronic_disease,51:69:chronic_disease,116:131:chronic_disease | presence of a severe psychiatric condition (i.e., psychotic disorder or episode) or a psychiatric condition (e.g., suicidal intent) that would contraindicate safe participation in the study as indicated by the medical chart, treating oncologist, or interactions with the medical/study staff | 3 | [
"presence",
"of",
"a",
"severe",
"psychiatric",
"condition",
"(",
"i.e.",
",",
"psychotic",
"disorder",
"or",
"episode",
")",
"or",
"a",
"psychiatric",
"condition",
"(",
"e.g.",
",",
"suicidal",
"intent",
")",
"that",
"would",
"contraindicate",
"safe",
"partic... | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02252081 | 12:35:treatment,39:45:treatment,,104:125:treatment | Use of any investigational product or device within 30 days prior to screening, or requirement for any investigational agent prior to completion of all scheduled study assessments | 3 | [
"Use",
"of",
"any",
"investigational",
"product",
"or",
"device",
"within",
"30",
"days",
"prior",
"to",
"screening",
",",
"or",
"requirement",
"for",
"any",
"investigational",
"agent",
"prior",
"to",
"completion",
"of",
"all",
"scheduled",
"study",
"assessments... | [
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02498301 | 22:61:treatment, | Subject received any systemic or gastrointestinal antibiotic in the 7 days prior to enrollment | 3 | [
"Subject",
"received",
"any",
"systemic",
"or",
"gastrointestinal",
"antibiotic",
"in",
"the",
"7",
"days",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02856412 | 27:50:allergy_name | Contraindications for the exercise treadmill test | 3 | [
"Contraindications",
"for",
"the",
"exercise",
"treadmill",
"test"
] | [
0,
0,
0,
4,
4,
4
] |
NCT02488967 | 8:17:chronic_disease,21:38:chronic_disease,69:80:treatment | Active infection or chronic infection requiring chronic suppressive antibiotics | 3 | [
"Active",
"infection",
"or",
"chronic",
"infection",
"requiring",
"chronic",
"suppressive",
"antibiotics"
] | [
0,
2,
0,
2,
2,
0,
0,
0,
1
] |
NCT01928576 | 42:52:cancer,54:56:cancer,70:96:cancer | Patients must have histologically proven stage IIIB, IV or recurrent non-small cell lung cancer | 3 | [
"Patients",
"must",
"have",
"histologically",
"proven",
"stage",
"IIIB",
",",
"IV",
"or",
"recurrent",
"non-small",
"cell",
"lung",
"cancer"
] | [
0,
0,
0,
0,
0,
3,
3,
0,
3,
0,
0,
3,
3,
3,
3
] |
NCT02383927 | 7:16:chronic_disease,22:25:chronic_disease,33:49:chronic_disease,55:66:chronic_disease,70:81:chronic_disease | Known infection with HIV, or an active infection with hepatitis B or hepatitis C | 3 | [
"Known",
"infection",
"with",
"HIV",
",",
"or",
"an",
"active",
"infection",
"with",
"hepatitis",
"B",
"or",
"hepatitis",
"C"
] | [
0,
2,
0,
2,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0
] |
NCT02544373 | 22:24:chronic_disease, | Evidence of clinical MS relapse within the last 30 days prior to enrollment | 3 | [
"Evidence",
"of",
"clinical",
"MS",
"relapse",
"within",
"the",
"last",
"30",
"days",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00930228 | 1:13:chronic_disease | Virilization | 3 | [
"Virilization"
] | [
2
] |
NCT01908777 | 1:46:cancer | Primary cutaneous gamma/delta T-cell lymphoma | 3 | [
"Primary",
"cutaneous",
"gamma/delta",
"T-cell",
"lymphoma"
] | [
3,
3,
3,
3,
3
] |
NCT01962415 | 17:26:chronic_disease | Other inherited metabolic disorders | 3 | [
"Other",
"inherited",
"metabolic",
"disorders"
] | [
0,
0,
2,
0
] |
NCT02053246 | 7:16:chronic_disease | Liver cirrhosis | 3 | [
"Liver",
"cirrhosis"
] | [
0,
2
] |
NCT01653080 | 1:44:chronic_disease | Acute or chronic severe renal insufficiency | 3 | [
"Acute",
"or",
"chronic",
"severe",
"renal",
"insufficiency"
] | [
2,
2,
2,
2,
2,
2
] |
NCT02665962 | 26:47:treatment,49:61:treatment,63:124:treatment,, | Scheduled for definitive surgical intervention (hysterectomy, bilateral salpingoopherectomy with or without lymphadenectomy) in the following 2-3 weeks as part of the standard of care | 3 | [
"Scheduled",
"for",
"definitive",
"surgical",
"intervention",
"(",
"hysterectomy",
",",
"bilateral",
"salpingoopherectomy",
"with",
"or",
"without",
"lymphadenectomy",
")",
"in",
"the",
"following",
"2-3",
"weeks",
"as",
"part",
"of",
"the",
"standard",
"of",
"car... | [
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01508390 | 10:22:treatment | No prior radiotherapy to the pelvis | 3 | [
"No",
"prior",
"radiotherapy",
"to",
"the",
"pelvis"
] | [
0,
0,
1,
0,
0,
0
] |
NCT02685358 | 26:33:chronic_disease | current intent to commit suicide | 3 | [
"current",
"intent",
"to",
"commit",
"suicide"
] | [
0,
0,
0,
0,
2
] |
NCT02553642 | 98:117:allergy_name | History of allergy to study drug component or history of severe hypersensitivity reaction to any monoclonal antibody | 3 | [
"History",
"of",
"allergy",
"to",
"study",
"drug",
"component",
"or",
"history",
"of",
"severe",
"hypersensitivity",
"reaction",
"to",
"any",
"monoclonal",
"antibody"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
4
] |
NCT03032432 | 1:14:chronic_disease | infraspinatus | 3 | [
"infraspinatus"
] | [
2
] |
NCT02323698 | 1:9:chronic_disease | Diabetes | 3 | [
"Diabetes"
] | [
2
] |
NCT02621944 | 33:42:treatment,,, | a cord blood/first hour of life blood gas with pH > 7.0 and < 7.15 | 3 | [
"a",
"cord",
"blood/first",
"hour",
"of",
"life",
"blood",
"gas",
"with",
"pH",
">",
"7.0",
"and",
"<",
"7.15"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01988246 | 23:29:treatment,34:42:treatment,,85:92:treatment | Use of topical ocular NSAIDS and steroids, in the study eye, within 7 days prior to surgery | 3 | [
"Use",
"of",
"topical",
"ocular",
"NSAIDS",
"and",
"steroids",
",",
"in",
"the",
"study",
"eye",
",",
"within",
"7",
"days",
"prior",
"to",
"surgery"
] | [
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02177838 | ,53:81:treatment,83:107:treatment,161:185:chronic_disease,189:199:chronic_disease, | Patients who have had either myocardial infarction, coronary artery bypass graft, coronary artery stenting, hospital admission for heart related issues such as congestive heart failure or arrhythmia within the last 3 months, will not be allowed on protocol | 3 | [
"Patients",
"who",
"have",
"had",
"either",
"myocardial",
"infarction",
",",
"coronary",
"artery",
"bypass",
"graft",
",",
"coronary",
"artery",
"stenting",
",",
"hospital",
"admission",
"for",
"heart",
"related",
"issues",
"such",
"as",
"congestive",
"heart",
"... | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02922023 | 17:43:chronic_disease,45:79:chronic_disease,81:89:chronic_disease,91:112:chronic_disease | Conditions with visual field deterioration (Anterior Ischemic Optic Neuropathy, Glaucoma, Optic Nerve Disorders) | 3 | [
"Conditions",
"with",
"visual",
"field",
"deterioration",
"(",
"Anterior",
"Ischemic",
"Optic",
"Neuropathy",
",",
"Glaucoma",
",",
"Optic",
"Nerve",
"Disorders",
")"
] | [
0,
0,
2,
2,
2,
0,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT00358657 | 1:4:chronic_disease | SAA diagnostic criteria may be applied to assessment at initial diagnosis or follow-up assessments | 3 | [
"SAA",
"diagnostic",
"criteria",
"may",
"be",
"applied",
"to",
"assessment",
"at",
"initial",
"diagnosis",
"or",
"follow-up",
"assessments"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02769000 | 18:41:treatment,55:77:treatment,95:98:treatment | Able to complete neurocognitive function assessments, psychological function assessments, and QOL assessments administered at screening visit | 3 | [
"Able",
"to",
"complete",
"neurocognitive",
"function",
"assessments",
",",
"psychological",
"function",
"assessments",
",",
"and",
"QOL",
"assessments",
"administered",
"at",
"screening",
"visit"
] | [
0,
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02522715 | 15:35:chronic_disease,78:94:chronic_disease,96:117:chronic_disease,131:155:chronic_disease,157:181:chronic_disease,183:201:chronic_disease,206:243:chronic_disease | Uncontrolled, intercurrent illness including, but not limited to, ongoing or active infection, uncontrolled diabetes, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements | 3 | [
"Uncontrolled",
",",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"uncontrolled",
"diabetes",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectori... | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03171168 | 28:58:chronic_disease | Patients with diagnosis of avascular necrosis of the knee | 3 | [
"Patients",
"with",
"diagnosis",
"of",
"avascular",
"necrosis",
"of",
"the",
"knee"
] | [
0,
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT03043742 | 13:38:chronic_disease | Evidence of left ventricular thrombus | 3 | [
"Evidence",
"of",
"left",
"ventricular",
"thrombus"
] | [
0,
0,
2,
2,
2
] |
NCT02389309 | 66:77:cancer,132:144:cancer,164:182:cancer,187:207:cancer | Patients must have had a previous histological verification of a solid tumor at the original diagnosis and/or recurrence including brain tumors; for patients with brain stem gliomas and optic pathway tumors, the requirement for histological evaluation may be waived | 3 | [
"Patients",
"must",
"have",
"had",
"a",
"previous",
"histological",
"verification",
"of",
"a",
"solid",
"tumor",
"at",
"the",
"original",
"diagnosis",
"and/or",
"recurrence",
"including",
"brain",
"tumors",
";",
"for",
"patients",
"with",
"brain",
"stem",
"gliom... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02379377 | 33:50:chronic_disease,, | Patients with poorly controlled diabetes mellitus (fasting blood glucose level > 200 mg/dL) | 3 | [
"Patients",
"with",
"poorly",
"controlled",
"diabetes",
"mellitus",
"(",
"fasting",
"blood",
"glucose",
"level",
">",
"200",
"mg/dL",
")"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00896493 | ,,14:50:cancer,,79:104:treatment,131:147:treatment | Stage IIB-IV mycosis fungoides or Sezary syndrome, who have failed at least 1 standard systemic therapy or are not candidates for standard therapy | 3 | [
"Stage",
"IIB-IV",
"mycosis",
"fungoides",
"or",
"Sezary",
"syndrome",
",",
"who",
"have",
"failed",
"at",
"least",
"1",
"standard",
"systemic",
"therapy",
"or",
"are",
"not",
"candidates",
"for",
"standard",
"therapy"
] | [
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01925573 | 31:44:treatment,46:57:treatment,74:90:chronic_disease,138:145:treatment | 9 Minimum interval since last major surgery, open biopsy, or significant traumatic injury is 4 weeks 10 Minimum interval since last drug therapy | 3 | [
"9",
"Minimum",
"interval",
"since",
"last",
"major",
"surgery",
",",
"open",
"biopsy",
",",
"or",
"significant",
"traumatic",
"injury",
"is",
"4",
"weeks",
"10",
"Minimum",
"interval",
"since",
"last",
"drug",
"therapy"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02379520 | 8:30:chronic_disease | Severe intercurrent infection | 3 | [
"Severe",
"intercurrent",
"infection"
] | [
0,
2,
2
] |
NCT02621944 | 11:38:chronic_disease,40:56:chronic_disease,62:74:chronic_disease | suspected inborn errors of metabolism (elevated ammonia) and hypoglycemia | 3 | [
"suspected",
"inborn",
"errors",
"of",
"metabolism",
"(",
"elevated",
"ammonia",
")",
"and",
"hypoglycemia"
] | [
0,
2,
2,
2,
2,
0,
2,
2,
0,
0,
2
] |
NCT02901314 | 1:9:chronic_disease,11:34:chronic_disease,38:44:cancer,48:123:chronic_disease | cachexia, end stage liver disease or cancer or non-ambulatory New York Heart Association functional class IV heart failure | 3 | [
"cachexia",
",",
"end",
"stage",
"liver",
"disease",
"or",
"cancer",
"or",
"non-ambulatory",
"New",
"York",
"Heart",
"Association",
"functional",
"class",
"IV",
"heart",
"failure"
] | [
2,
0,
2,
2,
2,
2,
0,
3,
0,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2
] |
NCT02048371 | 44:56:cancer, | Concurrent, clinically significant, active malignancies within 12 months of study enrollment | 3 | [
"Concurrent",
",",
"clinically",
"significant",
",",
"active",
"malignancies",
"within",
"12",
"months",
"of",
"study",
"enrollment"
] | [
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02845453 | 45:75:treatment,,,, | If subject in restricted setting/care (e.g. detox or residential treatment) for ≤ 2 weeks, then use ≥ 50% of days while outside of restricted setting (e.g. 7 days of substance use out of 14 days in unrestricted setting) | 3 | [
"If",
"subject",
"in",
"restricted",
"setting/care",
"(",
"e.g",
".",
"detox",
"or",
"residential",
"treatment",
")",
"for",
"≤",
"2",
"weeks",
",",
"then",
"use",
"≥",
"50",
"%",
"of",
"days",
"while",
"outside",
"of",
"restricted",
"setting",
"(",
"e.g... | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02587403 | 1:22:chronic_disease,,, | Uncontrolled diabetes (i.e. known HbA1C value > 7% within the last 6 weeks) | 3 | [
"Uncontrolled",
"diabetes",
"(",
"i.e",
".",
"known",
"HbA1C",
"value",
">",
"7",
"%",
"within",
"the",
"last",
"6",
"weeks",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03117556 | 16:46:cancer | Diagnosed with stage III/IV pancreatic cancer | 3 | [
"Diagnosed",
"with",
"stage",
"III/IV",
"pancreatic",
"cancer"
] | [
0,
0,
3,
3,
3,
3
] |
NCT02446457 | ,75:88:treatment, | agree to use two methods of contraception starting with the first dose of study therapy through 120 days after the last dose of study therapy | 3 | [
"agree",
"to",
"use",
"two",
"methods",
"of",
"contraception",
"starting",
"with",
"the",
"first",
"dose",
"of",
"study",
"therapy",
"through",
"120",
"days",
"after",
"the",
"last",
"dose",
"of",
"study",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01819480 | 1:37:cancer | supraglottic squamous cell carcinoma | 3 | [
"supraglottic",
"squamous",
"cell",
"carcinoma"
] | [
3,
3,
3,
3
] |
NCT00929006 | 1:19:chronic_disease,,62:64:chronic_disease,65:69:chronic_disease, | Hyperprolactinemia: Mild prolactin elevations may be seen in HA/PCOS, and elevations within 20% higher than the upper limit of normal will be accepted in this group | 3 | [
"Hyperprolactinemia",
":",
"Mild",
"prolactin",
"elevations",
"may",
"be",
"seen",
"in",
"HA/PCOS",
",",
"and",
"elevations",
"within",
"20",
"%",
"higher",
"than",
"the",
"upper",
"limit",
"of",
"normal",
"will",
"be",
"accepted",
"in",
"this",
"group"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02278250 | 33:52:treatment | Ongoing toxic manifestations of previous treatments | 3 | [
"Ongoing",
"toxic",
"manifestations",
"of",
"previous",
"treatments"
] | [
0,
0,
0,
0,
1,
1
] |
NCT01522768 | ,25:42:cancer,77:84:chronic_disease,86:103:chronic_disease,109:124:cancer,,,197:207:treatment, | At least one measurable metastatic lesion according to RECIST 1.1 criteria. Ascites, pleural effusions, and bone metastases are not considered measurable. Minimum indicator lesion size = 10 mm by helical CT or = 20 mm by conventional techniques. Pathological nodes must be = 15 mm by the short axis to be considered meas... | 3 | [
"At",
"least",
"one",
"measurable",
"metastatic",
"lesion",
"according",
"to",
"RECIST",
"1.1",
"criteria",
".",
"Ascites",
",",
"pleural",
"effusions",
",",
"and",
"bone",
"metastases",
"are",
"not",
"considered",
"measurable",
".",
"Minimum",
"indicator",
"les... | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02033616 | 1:17:chronic_disease,111:125:chronic_disease,129:147:chronic_disease | Active infection or other active medical condition that could be eminently life-threatening, including active blood clotting or bleeding diathesis | 3 | [
"Active",
"infection",
"or",
"other",
"active",
"medical",
"condition",
"that",
"could",
"be",
"eminently",
"life-threatening",
",",
"including",
"active",
"blood",
"clotting",
"or",
"bleeding",
"diathesis"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2
] |
NCT01591356 | 12:46:chronic_disease,42:45:chronic_disease,87:109:treatment | History of human immunodeficiency virus (HIV) or HIV-positive patients on combination antiretroviral therapy are ineligible | 3 | [
"History",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"or",
"HIV-positive",
"patients",
"on",
"combination",
"antiretroviral",
"therapy",
"are",
"ineligible"
] | [
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02360579 | 15:39:cancer | Patients with melanoma of uveal/ocular origin | 3 | [
"Patients",
"with",
"melanoma",
"of",
"uveal/ocular",
"origin"
] | [
0,
0,
3,
3,
3,
0
] |
NCT02397889 | 58:84:chronic_disease | Patients judged clinically to be at serious and imminent suicidal or homicidal risk | 3 | [
"Patients",
"judged",
"clinically",
"to",
"be",
"at",
"serious",
"and",
"imminent",
"suicidal",
"or",
"homicidal",
"risk"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT02520713 | 24:29:cancer,71:89:treatment,232:250:treatment | Refractory, defined as tumor progression after initiation of standard first line therapy without having achieved a prior partial or complete remission OR Biopsy proven residual disease at the completion of planned standard initial front-line therapy | 3 | [
"Refractory",
",",
"defined",
"as",
"tumor",
"progression",
"after",
"initiation",
"of",
"standard",
"first",
"line",
"therapy",
"without",
"having",
"achieved",
"a",
"prior",
"partial",
"or",
"complete",
"remission",
"OR",
"Biopsy",
"proven",
"residual",
"disease... | [
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02074631 | 11:36:treatment | Impending invasive dental procedure that would be expected to occur during study participation (through Day 360) | 3 | [
"Impending",
"invasive",
"dental",
"procedure",
"that",
"would",
"be",
"expected",
"to",
"occur",
"during",
"study",
"participation",
"(",
"through",
"Day",
"360",
")"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01903330 | 1:6:chronic_disease | ulcer | 3 | [
"ulcer"
] | [
2
] |
NCT02555189 | 1:16:treatment,20:37:treatment,45:63:treatment | Planned surgery or radiation therapy during protocol treatment | 3 | [
"Planned",
"surgery",
"or",
"radiation",
"therapy",
"during",
"protocol",
"treatment"
] | [
1,
1,
0,
1,
1,
0,
1,
1
] |
NCT02723994 | 21:37:chronic_disease | Positive screen for hepatitis B or C | 3 | [
"Positive",
"screen",
"for",
"hepatitis",
"B",
"or",
"C"
] | [
0,
0,
0,
2,
2,
2,
2
] |
NCT02004275 | 15:22:treatment,50:59:treatment,185:192:cancer,249:265:treatment,267:277:treatment,282:295:treatment | a new line of therapy also begins when a planned treatment-free interval is interrupted by the need to start treatment due to disease relapse/progression (e.g. a patient with relapsed myeloma achieves a partial response after a planned 8 cycles of cyclophosphamide, bortezomib and dexamethasone, enjoys an 8-month period... | 3 | [
"a",
"new",
"line",
"of",
"therapy",
"also",
"begins",
"when",
"a",
"planned",
"treatment-free",
"interval",
"is",
"interrupted",
"by",
"the",
"need",
"to",
"start",
"treatment",
"due",
"to",
"disease",
"relapse/progression",
"(",
"e.g",
".",
"a",
"patient",
... | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02816736 | 60:76:treatment | Currently hospitalized and listed status 1A, 1B or 1-4 for heart transplant | 3 | [
"Currently",
"hospitalized",
"and",
"listed",
"status",
"1A",
",",
"1B",
"or",
"1-4",
"for",
"heart",
"transplant"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01614197 | ,57:73:treatment | At least 42 days must have elapsed if other substantial marrow radiation | 3 | [
"At",
"least",
"42",
"days",
"must",
"have",
"elapsed",
"if",
"other",
"substantial",
"marrow",
"radiation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01815359 | 12:35:chronic_disease | History of cerebrovascular disease. that would limit study compliance or place the patient at unacceptable risk for participation in the study | 3 | [
"History",
"of",
"cerebrovascular",
"disease",
".",
"that",
"would",
"limit",
"study",
"compliance",
"or",
"place",
"the",
"patient",
"at",
"unacceptable",
"risk",
"for",
"participation",
"in",
"the",
"study"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01803451 | 18:35:treatment | Individuals with bariatric surgery | 3 | [
"Individuals",
"with",
"bariatric",
"surgery"
] | [
0,
0,
1,
1
] |
NCT02465541 | 17:33:chronic_disease,58:79:chronic_disease,89:104:chronic_disease,118:142:chronic_disease,144:169:chronic_disease | Severe heart or systemic disease: evidence of documented myocardial infarction, chronic unstable angina, symptomatic congestive heart failure, uncontrolled hypertension | 3 | [
"Severe",
"heart",
"or",
"systemic",
"disease",
":",
"evidence",
"of",
"documented",
"myocardial",
"infarction",
",",
"chronic",
"unstable",
"angina",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"uncontrolled",
"hypertension"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2
] |
NCT02359097 | 47:63:chronic_disease | Subjects with clinically significant signs of uncal herniation, such as acute pupillary enlargement, rapidly developing motor changes (over hours), or rapidly decreasing level of consciousness | 3 | [
"Subjects",
"with",
"clinically",
"significant",
"signs",
"of",
"uncal",
"herniation",
",",
"such",
"as",
"acute",
"pupillary",
"enlargement",
",",
"rapidly",
"developing",
"motor",
"changes",
"(",
"over",
"hours",
")",
",",
"or",
"rapidly",
"decreasing",
"level... | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01959204 | 27:31:allergy_name,43:47:allergy_name,85:94:allergy_name,115:120:allergy_name | Has a history of relevant drug allergies, food allergies, or both (i.e., allergy to oxycodone, allergy to related drugs, or any significant food allergy that could interfere with the study) | 3 | [
"Has",
"a",
"history",
"of",
"relevant",
"drug",
"allergies",
",",
"food",
"allergies",
",",
"or",
"both",
"(",
"i.e.",
",",
"allergy",
"to",
"oxycodone",
",",
"allergy",
"to",
"related",
"drugs",
",",
"or",
"any",
"significant",
"food",
"allergy",
"that",... | [
0,
0,
0,
0,
0,
4,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02589938 | 15:42:treatment | have received bilateral radiation therapy, and subsequently developed grade 2 or 3 xerostomia, according to modified RTOG scale | 3 | [
"have",
"received",
"bilateral",
"radiation",
"therapy",
",",
"and",
"subsequently",
"developed",
"grade",
"2",
"or",
"3",
"xerostomia",
",",
"according",
"to",
"modified",
"RTOG",
"scale"
] | [
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02414269 | 21:55:chronic_disease,57:68:chronic_disease,94:105:chronic_disease | Negative screen for human immunodeficiency virus (HIV), hepatitis B virus (HBV) antigen, and hepatitis C virus (HCV) | 3 | [
"Negative",
"screen",
"for",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
",",
"hepatitis",
"B",
"virus",
"(",
"HBV",
")",
"antigen",
",",
"and",
"hepatitis",
"C",
"virus",
"(",
"HCV",
")"
] | [
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02346526 | ,,134:144:treatment | Subjects must agree to use adequate contraception beginning at the signing of the ICF until at least 6 months after the last dose of study drug | 3 | [
"Subjects",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"beginning",
"at",
"the",
"signing",
"of",
"the",
"ICF",
"until",
"at",
"least",
"6",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"drug"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02354547 | ,64:83:treatment | At least 3 half-lives of the antibody after the last dose of a monoclonal antibody | 3 | [
"At",
"least",
"3",
"half-lives",
"of",
"the",
"antibody",
"after",
"the",
"last",
"dose",
"of",
"a",
"monoclonal",
"antibody"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02670044 | 12:55:chronic_disease, | History of symptomatic Clostridium difficile infection within 1 month prior to dosing | 3 | [
"History",
"of",
"symptomatic",
"Clostridium",
"difficile",
"infection",
"within",
"1",
"month",
"prior",
"to",
"dosing"
] | [
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT00719888 | 68:98:cancer,,150:164:cancer,168:191:cancer,,345:363:cancer | patients who do not have high-risk features (for example preceding myelodysplastic syndrome [MDS], high-risk cytogenetics, >= 2 cycles to obtain CR, erythroblastic or megakaryocytic leukemia or >= CR2) must be discussed with the principal investigator (PI) prior to enrollment and at the Patient Care Conference or equiv... | 3 | [
"patients",
"who",
"do",
"not",
"have",
"high-risk",
"features",
"(",
"for",
"example",
"preceding",
"myelodysplastic",
"syndrome",
"[",
"MDS",
"]",
",",
"high-risk",
"cytogenetics",
",",
">",
"=",
"2",
"cycles",
"to",
"obtain",
"CR",
",",
"erythroblastic",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3... |
NCT01959698 | 29:37:allergy_name,41:53:allergy_name,54:64:allergy_name,84:95:allergy_name | Known history of allergy to Captisol (a cyclodextrin derivative used to solubilize carfilzomib) | 3 | [
"Known",
"history",
"of",
"allergy",
"to",
"Captisol",
"(",
"a",
"cyclodextrin",
"derivative",
"used",
"to",
"solubilize",
"carfilzomib",
")"
] | [
0,
0,
0,
0,
0,
4,
0,
0,
4,
4,
0,
0,
0,
4,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.